FDA Inspection 1302076 - InvaGen Pharmaceuticals, Inc. - February 09, 2026

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns InvaGen Pharmaceuticals, Inc., with an inspection on February 9, 2026, issued by the New York District Office, covering human drugs.

Company: InvaGen Pharmaceuticals, Inc.
Inspection Date: February 9, 2026
Product Type: Human Drugs
Office: New York District Office

Open in Dashboard

ID · 6f49afaf-f928-4ba0-a5bc-1df3f32d761d

Violation Codes2

21 CFR 211.6321 CFR 211.68(b)

Full citation text and observation details available on the Dashboard.